Chinese Medicine Treatment for Afatinib-Induced Paronychia
Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the we...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2017/7327359 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832548158004002816 |
|---|---|
| author | Pei-Yuu Yang Chen-Jei Tai |
| author_facet | Pei-Yuu Yang Chen-Jei Tai |
| author_sort | Pei-Yuu Yang |
| collection | DOAJ |
| description | Afatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient’s condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia. |
| format | Article |
| id | doaj-art-eab2f45d2f9142c18defd46c0856d532 |
| institution | Kabale University |
| issn | 2090-6706 2090-6714 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Oncological Medicine |
| spelling | doaj-art-eab2f45d2f9142c18defd46c0856d5322025-02-03T06:42:10ZengWileyCase Reports in Oncological Medicine2090-67062090-67142017-01-01201710.1155/2017/73273597327359Chinese Medicine Treatment for Afatinib-Induced ParonychiaPei-Yuu Yang0Chen-Jei Tai1Department of Traditional Chinese Medicine, Taipei Medical University Hospital, Taipei 11031, TaiwanDepartment of Traditional Chinese Medicine, Taipei Medical University Hospital, Taipei 11031, TaiwanAfatinib (Gilotrif™) is widely used to treat patients with mutant activating epidermal growth factor receptor- (EGFR-) dependent lung adenocarcinoma; however, it has various adverse side effects. Here, we report a patient with afatinib-induced paronychia. After Chinese medicine treatment with the well-known anticancer Chinese herbs, Jen-Ren-Hwo-Minq-Saan, and decoction of Ban-Zhi-Lian (Scutellaria barbata) with Bai-Hua-She-She-Cao (Hedyotis diffusa Willd), patient’s condition was significantly improved. This shows that these Chinese medicines can not only be used in cancer treatment but also be used in the afatinib-induced paronychia.http://dx.doi.org/10.1155/2017/7327359 |
| spellingShingle | Pei-Yuu Yang Chen-Jei Tai Chinese Medicine Treatment for Afatinib-Induced Paronychia Case Reports in Oncological Medicine |
| title | Chinese Medicine Treatment for Afatinib-Induced Paronychia |
| title_full | Chinese Medicine Treatment for Afatinib-Induced Paronychia |
| title_fullStr | Chinese Medicine Treatment for Afatinib-Induced Paronychia |
| title_full_unstemmed | Chinese Medicine Treatment for Afatinib-Induced Paronychia |
| title_short | Chinese Medicine Treatment for Afatinib-Induced Paronychia |
| title_sort | chinese medicine treatment for afatinib induced paronychia |
| url | http://dx.doi.org/10.1155/2017/7327359 |
| work_keys_str_mv | AT peiyuuyang chinesemedicinetreatmentforafatinibinducedparonychia AT chenjeitai chinesemedicinetreatmentforafatinibinducedparonychia |